Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease
- PMID: 28521698
- DOI: 10.2174/0929867324666170516122024
Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease
Abstract
Since their first synthesis back in the early 20th century, 1,2,4-triazolo[1,5- a]pyrimidines have aroused increasing interest in very diverse areas ranging from chemotherapy to agriculture or even photography. Their similarity to purines confers a potential bioactivity and this feature has been wisely exploited for therapeutic use, including antifungal, antipyretic, analgesic, antiinflammatory, antitumoral and antiparasitic properties. In this review, we focus on the compounds that these nitrogen heterocycles form with metal ions and their antiparasitic activity and therapeutic potential against two neglected diseases of tropical prevalence, leishmaniasis and Chagas disease.
Keywords: Chagas disease; Leishmania; Triazolopyrimidine; Trypanosoma cruzi; leishmaniasis; metal complexes; neglected tropical diseases.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.J Inorg Biochem. 2014 Sep;138:39-46. doi: 10.1016/j.jinorgbio.2014.04.016. Epub 2014 May 6. J Inorg Biochem. 2014. PMID: 24861807
-
Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.J Inorg Biochem. 2017 Nov;176:144-155. doi: 10.1016/j.jinorgbio.2017.08.018. Epub 2017 Sep 1. J Inorg Biochem. 2017. PMID: 28910663
-
Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.Eur J Med Chem. 2014 Oct 6;85:526-34. doi: 10.1016/j.ejmech.2014.08.026. Epub 2014 Aug 10. Eur J Med Chem. 2014. PMID: 25127147
-
Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.Trop Biomed. 2011 Dec;28(3):471-81. Trop Biomed. 2011. PMID: 22433874 Review.
-
Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.Curr Med Chem. 2018;25(30):3637-3679. doi: 10.2174/0929867325666180309111428. Curr Med Chem. 2018. PMID: 29521209 Review.
Cited by
-
Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands.Molecules. 2022 Jan 24;27(3):765. doi: 10.3390/molecules27030765. Molecules. 2022. PMID: 35164029 Free PMC article.
-
Zinc from an Essential Element to an Antiparasitic Therapeutic Agent.ACS Omega. 2025 Jan 17;10(3):2393-2414. doi: 10.1021/acsomega.4c07331. eCollection 2025 Jan 28. ACS Omega. 2025. PMID: 39895759 Free PMC article. Review.
-
Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments.Biomedicines. 2025 Jul 6;13(7):1648. doi: 10.3390/biomedicines13071648. Biomedicines. 2025. PMID: 40722720 Free PMC article.
-
First-Row Transition 7-Oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes: Antiparasitic Activity and Release Studies.Pharmaceuticals (Basel). 2023 Sep 28;16(10):1380. doi: 10.3390/ph16101380. Pharmaceuticals (Basel). 2023. PMID: 37895851 Free PMC article.
-
Biological Activity of Triazolopyrimidine Copper(II) Complexes Modulated by an Auxiliary N-N-Chelating Heterocycle Ligands.Molecules. 2021 Nov 9;26(22):6772. doi: 10.3390/molecules26226772. Molecules. 2021. PMID: 34833864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical